Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.

Saved in:
Bibliographic Details
Title: Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.
Authors: Feng B; Department of Pharmacokinetics, Pharmacodynamics, Drug Metabolism, Pfizer Global Research & Development, Groton, Connecticut, USA., Obach RS, Burstein AH, Clark DJ, de Morais SM, Faessel HM
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2008 Apr; Vol. 83 (4), pp. 567-76. Date of Electronic Publication: 2007 Oct 31.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-6535
DOI:10.1038/sj.clpt.6100405